Introduction
Borrelia spirochaetes dispose of the package of proteins facilitating adjustment to: the microenvironment conditions in a speci ic organism, survival in those conditions, tissues colonization, and facilitate the ability to change the host. Since a considerable number of spirochaetes proteins is characterized by high immunogenicity, they are also signi icant from the perspective of diagnosis of Borrelia infections in humans. The most signi icant marker for early-stage infection are IgM antibodies directed against to OspC protein. They have signi icance diagnostic meaning and decreases in the period of late anti-Borrelia response. After that immunodominant role is taken over by VlsE, p30, DbpA . Although the antigens from in vivo group are most commonly speci ied as distinctive for the late Lyme disease stage, researches have shown that we can ind them in patients with early stage borreliosis . The appearance and disappearance of antibodies to various antigenic proteins of Borrelia is therefore a dynamic and time-variable process. It is a matter for people occupationally exposed to tick bites. Foresters are expose to multiple tick bites, and high risk of being infected with Borrelia.
Antibodies for in vivo B. burgdorferi...
The aim of work
The aim of our work was analysis of speci ic immune response for B. burgdorferi according to in vivo antigens in regard to symptoms subjectively perceived by foresters, in 2009 and 2012.
Material and methods
The study group include 41 foresters (19 to 86 years), from one forest district in Lubelskie region. The screening test Elisa (Euroimmun) has been carried among all persons from the tested group towards the presence of antibodies IgM/IgG anti-Borrelia. Among those who met positive or delimited results from screening test Elisa, another test of Western blot (Wb, Euroimmun) has been carried in order to con irm the infection. The subjects who met positive results of Wb (Euroimmun) test with the presence of antibodies IgM and/or IgG anti-Borrelia have been submitted to broader diagnostic tests regarding the infection with B. burgdorferi. The antibodies IgG has been detected for in vivo antigens of Borrelia burgdorferi: BBA36, BBO323, CRASP3, pG (Virotech GmbH). The study was carried out in two periods: December 2009 and then the same people again, in December 2012. Also the surveys were taken. We asked about: tick bites in 2009-2012 period, presence of erythema migrans (EM) in that period, and others symptoms which can be associated with being bitten by a tick, and antibiotic therapy. The study obtained the approval of the bioethics committee.
Results
The 32% foresters from study group have not immune response for IgM/IgG anti-B. burgdorferi in two diagnostic periods (2009, 2012 In 2009 one forester (2%) had IgG anti-VlsE antibodies, and he reported osteoarticular pains and antibiotic treatment (table 5 ). In the test in 2012, there was no presence of anti-Borrelia antibodies in any class in his serum. Forester declared the existence of another tick bite in spring 2012, the occurrence of EM, and informed about used treatment because of EM.
His pain declared in 2009 remained and during the test in December 2012. The existence of clinical symptoms associated with Lyme disease does not exclude the occurrence of early skin manifestations (EM) after subsequent ticks bites. Antibiotics, used in accordance with the recommendations, successfully stopped the process of early new infection as evidenced by the lack of speci ic IgM antibodies. Despite multiple treatments, there was not satisfactory elimination of other symptoms for the patient that had existed after the irst infection. (Table 6 ). They informed about existence of clinical symptoms and treatment used. Probably it can be presumed that kind of serological status is associated with existence of Borrelia infection in 2009, which was eliminated. However, in 2012, was a re-infection with B. burgdorferi. Foresters are still exposed to multiple bites by ticks, so one cannot rule out the existence of occurring infections. In 15 foresters (36%) treated by antibiotics had still strongly expressed immune response occurred as IgM/ IgG anti-Borrelia (Table 7) . During 2009 -2012 period they were repeatedly stinging by ticks and they declared symptoms of osteoarthritis, muscle pain, and headache. In 7 out of 15 foresters (47%) there was persistence of response against the same antigens from in vivo group (grey boxes in Table 7 ). In case of the next 7 people in this subgroup (47%) there was some dynamics: the disappearance or appearance of IgG to speci ic antigens from in vivo group. It showed us that the process of immunostimulation is active, time-varying and possibly associated with Borrelia strategies (black boxes in Table 7 ). We observed different frequencies-disappearance of IgG to speci ic proteins BBA36, BBO323, CRASP3 and pG in 4 of 15 patients (27%). In 3 people (20%) there was appearance of IgG antibodies for the same in vivo antigens. The only exception was IgG anti-VlsE antibodies. It was consistently reported in all of subgroup (15 people) infected with B. burgdorferi. 
BBO323, CRASP3
Grey box -persistence of antibodies to the in vivo antigen within three years from the last study Black box -the appearance or disappearance of IgG antibodies for the in vivo antigen within three years from the last study
Discussion
The immune response to infection with B. burgdorferi occurs in a diverse and individual pace. It should be taken into consideration while estimating the clinical and serological status of each patient. Clinical symptoms of Lyme disease may not be eliminated despite the implemented treatment. Simultaneously there may be strongly expressed stimulation of the production of IgG anti-Borrelia antibodies. The presence of IgG antibodies to the in vivo antigen indicates their importance in the late response to infection with Borrelia. Appearance and disappearance of antibodies to in vivo proteins shows continued availability of bacterial antigens to the host organism and long-term immune stimulation. The treatment used in Lyme disease may be effective and lead to the total elimination disease symptoms, and disappearance of speci ic antibodies. In some cases, despite of antibodies elimination there is no symptoms reduction of Lyme diseases. It may suggest existence of post-treatment Lyme disease syndrome (PTLDS). The PTLDS can be signalized if symptoms associated with Borrelia infection are persistent, and last longer than 6 months after treatment. According to the guidelines, this condition does not justify the use of antibiotics, which is referred as useless and potentially harmful to the patient with PTLDS (Lakos, 2012 , CDC, 2011 . Then the medical and laboratory activities should be focused on assessing the effectiveness of treatment, exclusion of possible failure of therapy or taking into account other factor which is not related to Borrelia infection (Lakos, 2012 , CDC, 2011 . The cause of PTLDS is not completely clear. It is assumed that these symptoms may be related to the elements of tissue damage or dysfunction of the immune system during the infection. Similar complications including autoimmune reactions may occur in other infectious diseases (CDC, 2011). Long-standing persistence of symptoms that may be associated with PTLDS is an important and strongly noticed problem of both doctors and physiotherapists.
The obtained results indicate the advisability of annual tests for Borrelia infection for people working in conditions predisposing to infection. Unfortunately, in the vast majority of forest districts, the employer inances only the irst stage of diagnosis (ELISA tests). Con irming tests (Wb) employees found on their own.
In practice it means that many people who are advised to do a con irmation test do not do such tests. At the moment there is no legislation which would impose an obligation on employers to perform a full, two-stage diagnosis in the direction of Lyme disease.
Conclusions
Analysis of appearance and disappearance antibodies to Borrelia antigens expressed in vivo showed, how active, long and time-varying process is this infection. This forces an individual approach to each patient, in whom there is a suspicion of Lyme disease. What is more it imposes a need to consider often ambiguous serological results with clinical manifestations of infection. Especially it is important for people exposed to Borrelia infection on the grounds of their occupation.
The expression of individual proteins of spirochetes and their exceptionally high immunogenicity make diagnostic procedure effective. It is postulated that the use of a wider range of antigens B. burgdorferi from in vivo group: BBA36, BBO323, CRASP3 and pG in Western blot diagnostic tests could help to increase diagnostic accuracy in dif icult and ambiguous cases of B. burgdorferi infection.
